Medicare Enrolled
Dr. Patrick Parker, D.O.
Urology Physician · Valdosta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parker
Dr. Patrick Parker is an urology physician in Valdosta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Parker performed 91,896 Medicare services across 6,367 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parker received a total of $13,179 from 56 pharmaceutical and/or device companies across 460 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in GA
$13,179 industry payments
Medicare Practice Summary
Medicare Utilization ↗91,896
Medicare services
Top 0% in GA for urology physician
6,367
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,837 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
77,250 | $1 | $4 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
3,965 | $2 | $25 |
| Denosumab injection (Prolia/Xgeva) | 3,720 | $18 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,842 | $87 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,258 | $61 | $175 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
382 | $7 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
313 | $10 | $75 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 293 | $134 | $600 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
257 | $61 | $675 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
195 | $113 | $351 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
166 | $508 | $4,378 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
157 | $69 | $350 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
150 | $42 | $220 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
113 | $38 | $2,100 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
98 | $39 | $105 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
81 | $61 | $340 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
78 | $9 | $265 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
60 | $16 | $55 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
57 | $104 | $1,526 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
54 | $24 | $150 |
| Simple change of bladder tube | 49 | $68 | $320 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 42 | $3 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $72 | $220 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
28 | $91 | $610 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
27 | $111 | $800 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
27 | $283 | $1,500 |
| Insertion of temporary bladder tube | 26 | $33 | $170 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
25 | $158 | $3,000 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
22 | $307 | $4,500 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
20 | $430 | $3,000 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
20 | $546 | $2,400 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $22 | $625 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
17 | $179 | $850 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
16 | $106 | $1,400 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
15 | $206 | $1,500 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
11 | $263 | $795 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
11 | $126 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
89.0% medium
10.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,179
Total received (2018-2024)
Avg $1,883/year across 7 years
Top 17% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
460
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,747 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$432 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,122
2023
$2,470
2022
$1,180
2021
$1,133
2020
$878
2019
$3,488
2018
$2,907
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$175
PROCEPT BioRobotics Corporation
$170
PFIZER INC.
$112
Antares Pharma, Inc.
$92
Boston Scientific Corporation
$92
Sumitomo Pharma America, Inc.
$87
COLOPLAST CORP
$66
ABBVIE INC.
$53
Janssen Biotech, Inc.
$40
Merck Sharp & Dohme LLC
$39
Ferring Pharmaceuticals Inc.
$31
Tolmar, Inc.
$28
Endo USA, Inc.
$22
LSI SOLUTIONS INC
$22
Endo Pharmaceuticals Inc.
$19
Tempus AI, Inc
$16
STERIS CORPORATION
$16
Bayer Healthcare Pharmaceuticals Inc.
$14
C. R. Bard, Inc. & Subsidiaries
$14
Astellas Pharma US Inc
$13
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$2,282
PROCEPT BioRobotics Corporation
$1,370
Astellas Pharma US Inc
$1,335
NeoTract Inc.
$1,213
Coloplast Corp
$897
Myriad Genetic Laboratories, Inc.
$808
Endo Pharmaceuticals Inc.
$758
Antares Pharma, Inc.
$516
PFIZER INC.
$510
Teleflex LLC
$298
Janssen Biotech, Inc.
$223
Allergan Inc.
$213
Olympus America Inc.
$192
Sumitomo Pharma America, Inc.
$176
COLOPLAST CORP
$149
Bayer Healthcare Pharmaceuticals Inc.
$144
Dendreon Pharmaceuticals LLC
$130
Bayer HealthCare Pharmaceuticals Inc.
$126
Amgen Inc.
$125
Intuitive Surgical, Inc.
$117
Janssen Products, LP
$99
Clarus Therapeutics Inc.
$98
ABBVIE INC.
$92
Avadel Specialty Pharmaceuticals, LLC
$92
AMAG Pharmaceuticals, Inc.
$91
AbbVie, Inc.
$88
TOLMAR Pharmaceuticals, Inc.
$81
Sun Pharmaceutical Industries Inc.
$79
UROVANT SCIENCES INC
$78
Ferring Pharmaceuticals Inc.
$71
Allergan, Inc.
$63
180 Medical, Inc.
$58
Myovant Sciences Inc.
$57
Tolmar, Inc.
$52
BOSTON SCIENTIFIC CORPORATION
$51
Duchesnay USA Incorporated
$47
MEDIVATION FIELD SOLUTIONS LLC
$39
Merck Sharp & Dohme LLC
$39
C. R. Bard, Inc. & Subsidiaries
$32
UROGEN PHARMA, INC.
$31
Aytu BioScience, Inc
$29
Endo USA, Inc.
$22
Telix Pharmaceuticals
$22
UroGen Pharma, Inc.
$22
LSI SOLUTIONS INC
$22
Palette Life Sciences, Inc.
$21
C. R. BARD, INC. & SUBSIDIARIES
$16
Tempus AI, Inc
$16
STERIS CORPORATION
$16
AbbVie Inc.
$15
Medtronic, Inc.
$14
Axonics, Inc.
$13
Medtronic USA, Inc.
$13
Ambu Inc.
$9
Travere Therapeutics, Inc.
$5
Retrophin, Inc.
$1
Top 3 companies account for 37.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bonjesta · CONTINENCE CARE · Coloplast TFL Drive · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL - THERAPIES · GENTLECATH · ILLUCCIX · INTERSTIM · INTRAROSA · JATENZO · JELMYTO · JNW URTRAC · KEYTRUDA · LUPRON DEPOT · LithoVue · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Olympus Cysto-Resection · Olympus Digital Flexible Ureteroscopes · Olympus Resection Disposables · Osphena · Otrexup · PREMARIN · PROLARIS · PROVENGE · PVC · Prolaris · Prolia · REZUM · Rezum Generator · SPACEOAR VUE · SPEEDICATH · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · TOVIAZ · Thiola · Tria Firm · UROLIFT · Uretero1 · UroLift · UroLift System · Veozah · XGEVA · XIAFLEX · XT CDX · XTANDI · XYOSTED · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
2
Per 100K population
1.7
County median income
$55,887
Nearest hospital
SGMC HEALTH
8.4 mi
8.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parker is a mixed practice specialist, with above-average Medicare volume (top 0% in GA), with low-engagement industry engagement in the top 17% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parker experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Parker performed 77,250 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parker receive payments from pharmaceutical companies?
Yes. Dr. Parker received a total of $13,179 from 56 companies across 460 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parker's costs compare to other urology physicians in Valdosta?
Dr. Parker's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Valdosta
Browse urology physicians in Valdosta ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology